Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1996
08/06/1996US5543520 Pyrimidine derivatives
08/06/1996US5543518 Red-shifted tris-aryl-s-triazines and compositions stabilized therewith
08/06/1996US5543435 Using limonen-10-ol to kill bacteria, yeast, and fungi
08/06/1996US5543434 Nasal administration of ketamine to manage pain
08/06/1996US5543430 Method and formulation of stimulating nitric oxide synthesis
08/06/1996US5543428 Administering substituted phenoxyalkyl compounds to reverse drug resistance
08/06/1996US5543426 Use of certain 3,7-disubstituted indole compounds for treating depression or cognitive disorders
08/06/1996US5543423 Amino acid derivatives with improved multi-drug resistance activity
08/06/1996US5543422 Heterocyclic amines
08/06/1996US5543421 Method of treatment of peripheral neuropathies and central neurodegenerative diseases
08/06/1996US5543420 Aldose reductase inhibitors; antidiabetic agents; prevention of accumulation of sorbitol and galactitol in mammalian tissue
08/06/1996US5543419 Treating chronic obstructive airways disease or asthma; antimuscarinic bronchodilator agents
08/06/1996US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements
08/06/1996US5543417 Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
08/06/1996US5543415 Antidepressants
08/06/1996US5543414 Viricides
08/06/1996US5543413 Heterocyclic thioamides and related analogs as antiviral agents with a unique mode of action
08/06/1996US5543412 Administering a benzoyl piperazin quinolins viricides
08/06/1996US5543411 Hydroxylated metabolites and derivatives of doxazosin as anti-atherosclerosis agents
08/06/1996US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof
08/06/1996US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/06/1996US5543407 Using scopolamine hydrobromide and chlorpromazine hydrochloride; high speed therapy for narcotic and alcohol dependency
08/06/1996US5543406 Inhibitors of 5-α-testosterone reductase
08/06/1996US5543405 Composition and method for weight reduction and long term management of obesity
08/06/1996US5543402 Antitumor agents
08/06/1996US5543401 UDPG as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without BAU
08/06/1996US5543400 Antibiotics
08/06/1996US5543389 Ointment containing antiproliferative drug bound to lipid carrier through linking and spacer groups, for rapid efficient drug delivery in treatment of skin disorders
08/06/1996US5543154 Water insoluble coating having apertures through which surrounded core material comprising nifedipine mixed with polyacrylate polymer which hydrates into microparticle gel is released in situ
08/06/1996US5543153 Antacid
08/06/1996US5543150 Method of progesterone delivery and affect thereof
08/06/1996US5543148 Mixture of solvent, gelling agent and treatment agent
08/06/1996US5543147 Antiinflammatory and wound healing acitivity
08/06/1996US5543099 Process to manufacture micronized nifedipine granules for sustained release medicaments
08/06/1996CA2037923C Oxindole derivative
08/06/1996CA1338509C Viscoelastic material for ophthalmic surgery
08/06/1996CA1338508C Method and compositions for treatment of parkinsonism syndrome in mammals
08/04/1996CA2168330A1 Procedure for encapsulating chlorpheniramine
08/02/1996CA2168513A1 Preventive or alleviative agent for hypertension or medical symptoms caused thereby
08/02/1996CA2168320A1 Substituted indole derivatives
08/02/1996CA2168317A1 Use of phenylcyclohexylcarboxamides
08/01/1996WO1996023225A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
08/01/1996WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides
08/01/1996WO1996023059A1 Lineage-directed induction of human mesenchymal stem cell differentiation
08/01/1996WO1996023003A1 A therapeutic molecule
08/01/1996WO1996022998A1 Thiol derivatives with metallopeptidase inhibitory activity
08/01/1996WO1996022997A1 Compounds with growth hormone releasing properties
08/01/1996WO1996022994A1 Bismuth compounds
08/01/1996WO1996022992A1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
08/01/1996WO1996022991A1 Bicyclic substituted hexahydrobenz[e]isoindole alpha-1- adrenergic antagonists
08/01/1996WO1996022990A2 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
08/01/1996WO1996022989A1 Novel 9h-pyrido[3,4-b]indol derivatives
08/01/1996WO1996022985A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
08/01/1996WO1996022984A1 METHOD FOR PREPARING 4,10-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β-DIHYDROXY-9-OXO-TAX-11-EN-13α-YL (2R,3S)-3-BENZOYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE TRIHYDRATE
08/01/1996WO1996022979A1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
08/01/1996WO1996022978A1 Substituted phenyl compounds as endothelin antagonists
08/01/1996WO1996022976A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
08/01/1996WO1996022966A1 Cell adhesion inhibitors
08/01/1996WO1996022965A1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
08/01/1996WO1996022955A1 Improved synthesis of cyclopropylacetylene
08/01/1996WO1996022792A1 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
08/01/1996WO1996022791A1 Novel synergistic compositions useful as anti-tumor or anti-retroviral agents
08/01/1996WO1996022790A1 Composition to ameliorate osteolysis and metastasis
08/01/1996WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof
08/01/1996WO1996022784A1 Novel antifungal cyclohexapeptides
08/01/1996WO1996022780A1 Methods of enhancing the therapeutic activity of nsaids and compositions of zwitterionic phospholipids useful therein
08/01/1996WO1996022779A1 Muscular dystrophy progression depressant
08/01/1996WO1996022778A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/01/1996WO1996022777A1 Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
08/01/1996WO1996022776A1 Dermatological use of vitamin d derivatives
08/01/1996WO1996022774A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
08/01/1996WO1996022773A1 Methods and compositions for lipidization of hydrophilic molecules
08/01/1996WO1996022772A1 Method for treating multiple sclerosis
08/01/1996WO1996022771A1 Methods of inhibiting environmental estrogens
08/01/1996WO1996022769A1 Method for treating multiple sclerosis
08/01/1996WO1996022768A1 Extended release clonidine formulation
08/01/1996WO1996022764A1 Liposomes containing a corticosteroid
08/01/1996WO1996016052A3 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
08/01/1996WO1996013259A3 Method and compositions for inhibiting protein kinases
08/01/1996WO1996006604A3 Methods for identifying and treating resistant tumors
08/01/1996WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
08/01/1996DE19502795A1 New benzoyl-guanidine cpds. with base-substd. phenyl- or naphthyl- gp.
08/01/1996CA2546745A1 Nucleosides with [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
08/01/1996CA2211873A1 Bismuth compounds
08/01/1996CA2211608A1 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
08/01/1996CA2211442A1 Methods and compositions for lipidization of hydrophilic molecules
08/01/1996CA2211212A1 Tricyclic substituted hexahydrobenz¬e|isoindole alpha-1 adrenergic antagonists
08/01/1996CA2211181A1 Cell adhesion inhibitors
08/01/1996CA2211176A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
08/01/1996CA2211138A1 Novel antifungal cyclohexapeptides
08/01/1996CA2210966A1 Bicyclic substituted hexahydrobenz[e]isoindole alpha-1- adrenergic antagonists
08/01/1996CA2210940A1 Methods of inhibiting environmental estrogens
08/01/1996CA2210884A1 Dermatological use of vitamin d derivatives
08/01/1996CA2210662A1 Method for treating multiple sclerosis
08/01/1996CA2210577A1 Improved synthesis of cyclopropylacetylene
08/01/1996CA2210566A1 Method for treating multiple sclerosis
08/01/1996CA2210501A1 New 9h-pyrido 3,4-b indole derivatives
08/01/1996CA2210482A1 Liposomes containing a corticosteroid
08/01/1996CA2210151A1 Thiol derivatives with metallopeptidase inhibitory activity
08/01/1996CA2208075A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
1 ... 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 6905 6906 6907 6908 6909 6910 6911 6912 6913 ... 7860